Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery

Platform Integrates Three Research Modalities Targeting the Electrical Properties of Tumor Biology in Pancreatic Cancer MEQUON, Wis., May 1, 2026 /PRNewswire/ -- (TSXV: PAIN) — Vector Science & Therapeutics (the "Company") today announced the filing of a provisional patent application...